サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：生物学的データ可視化市場の規模、シェア、動向分析レポート：技術別（顕微鏡、シーケンス）、用途別（システムバイオロジー）、プラットフォーム別、最終用途別、地域別、セグメント別予測、2022年～2030年
市場調査レポート
商品コード
1147524

生物学的データ可視化市場の規模、シェア、動向分析レポート：技術別（顕微鏡、シーケンス）、用途別（システムバイオロジー）、プラットフォーム別、最終用途別、地域別、セグメント別予測、2022年～2030年

Biological Data Visualization Market Size, Share & Trends Analysis Report By Technique (Microscopy, Sequencing), By Application (Systems Biology), By Platform, By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
生物学的データ可視化市場の規模、シェア、動向分析レポート：技術別（顕微鏡、シーケンス）、用途別（システムバイオロジー）、プラットフォーム別、最終用途別、地域別、セグメント別予測、2022年～2030年
出版日: 2022年10月17日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

生物学的データ可視化市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界の生物学的データ可視化市場規模は2030年までに13億米ドルに達すると予測されています。同市場は2022年から2030年にかけてCAGR12.0％で拡大すると予測されています。ゲノミクスとプロテオミクスの研究の高まりは、主要な市場促進要因の1つです。市場の主要企業は、生物学的データ可視化市場でのシェアを拡大するために、新製品の発売、M&A、技術提携などの戦略的な取り組みに注力しています。例えば、2021年8月、DNAnexus, Inc.は、生物医学情報学プラットフォームの規格が、米国政府の最近の行政命令で示されたオンラインセキュリティ政策目標を上回ったと発表しました。これにより、NGSエンドユーザーの製品に対する信頼が高まり、大規模なバイオメディカル情報を高いセキュリティで管理することを支援しました。

ライフサイエンスの研究者や実務家は、生物情報の理解と解釈における幅広い課題を解決するために、可視化技術に依存しています。生の計算能力とグラフィックス処理能力の急速な進歩により、汎用的なデスクトッププラットフォームで生物学的情報の可視化が容易に行えるようになりました。さらに、次世代シーケンス（NGS）技術やその他の生物学的データ取得アプローチの採用が増加し、新しいタイプのデータセットが生成されるため、研究者や科学者の間で可視化ツールに対する需要が高まっています。

例えば、スペインはNGSデータ解析のための魅力的で競争力のある市場になっています。2020年9月、スペイン政府は、精密・ゲノム医療、データサイエンスに2950万米ドルを割り当てました。この投資は、地域の医療システムの能力を高め、イノベーションに貢献することで経済的競争力を抱かせるツールとして科学的知識を活用することを目的としています。2年間（2020-22年）に割り当てられた資金総額は8,933万米ドルです。投資の区分は、ゲノム医療、ビッグデータヘルス、予測医療、先進・個別化治療、精密医療トレーニングなどです。

COVID-19の大流行により、シークエンス情報分析プラットフォームの利用が増加し、ウイルスの検出と追跡で重要な役割を果たし、生物学的データ可視化市場の成長を支えています。様々なシーケンス監視プラットフォームとソリューションは、感染の効果的な診断のために配備されています。さらに、主要な利害関係者は、この病気と闘うために、共同研究のためのコラボレーションやライセンス供与など、さまざまな戦略的取り組みを行っています。例えば、2021年2月、カナダ政府はCOVID-19の診断に多層的なアプローチを実施するために5,300万米ドルを投資しました。カナダ政府は、ゲノム配列解析技術を活用し、望ましい結果を達成する予定です。

分析およびビジネスインテリジェンスソリューションの技術的進歩と、ビッグデータの急速な増加、意思決定の迅速化のニーズの高まりは、バイオインフォマティクス分野における可視化ツールの需要を押し上げる他のいくつかの要因です。膨大な量の高次元生物学的情報は、人間の専門家が容易に理解できるように、機械学習と高度なデータ可視化アプローチを必要とします。

一方、生物学的データ可視化市場は、大規模な世界プレーヤーから小規模なローカルまたは地域プレーヤーまで、相当数の企業が存在する断片的な性質を持っています。市場で事業を展開している公開キーベンダには、QIAGEN、Thermo Fisher Scientific Inc.、Agilent Technologies, Inc.、Becton-Dickinson and Company、3Mなどがあります。

生物学的データ可視化市場のレポートハイライト

技術別では、2021年にシーケンシングが大きなシェアを占めると推定されます。シーケンシングによって生成される大量の情報は、データ管理ソリューションとプラットフォームを必要とし、その結果、生物学研究用のツール＆アルゴリズムに対する高い需要が発生しています。

アプリケーション別では、ゲノム解析分野が2021年の生物学的データ可視化市場で大きなシェアを占めると予測されます。新しいプラットフォーム開発のための投資の増加、分析ソリューションの採用に対する積極的なアプローチ、技術革新などの特定の要因が、このアプリケーションにおける新製品の発売を促進しています。

プラットフォーム別では、Mac OSが生物学的データ可視化市場で最も急速に成長すると予想されます。このOSは、ユーザーフレンドリーでシンプルな設計になっており、情報保護のためのセキュリティ機能も充実しているためです。

エンドユーザー別では、学術研究分野が2021年の市場シェアの大半を占めると予測されます。これは、次世代シーケンス（NGS）、およびX線結晶学的手法を研究中に使用し、データ可視化ツールを実装することに起因しています。したがって、これらの施設におけるそのような技術の実装の増加は、生物学的研究における研究結果を正確に観察するための可視化ツールの需要を促進します。

北米は、主要企業が現地に進出していること、ゲノム解析やシステムバイオロジーに関連する研究プロジェクトが多数あることから、2021年には生物学的データ可視化に関する地域市場として優位に立つと考えられています。

目次

第1章 調査手法

  • 国ごとの市場：基本推定
  • 世界市場：CAGR計算
  • 地域別セグメントシェア計算
  • 調査範囲と前提
  • データソースのリスト
    • 情報源別の一次インタビューのデータ
    • 地域別一次面接データ

第2章 エグゼクティブサマリー

  • 市場のスナップショット

第3章 生物学的データ可視化市場の変数、動向、および範囲

  • 市場系列の見通し
  • 市場力学
    • 市場促進要因分析
      • 生物学的データの急速な成長
      • 生体データ解析への人工知能の組み込み
      • より迅速な意思決定に対する需要の高まり
    • 市場抑制要因分析
      • データの視覚化に関するユーザーインターフェイスの課題
      • データ管理のための計算の一貫性の欠如
  • アプリケーションの浸透と成長の見通しマッピング、2021
  • 生体データの可視化市場-SWOT分析、要因別（政治と法律、経済と技術）
  • 業界分析- ポーターズ
  • 主要取引と戦略的提携分析
    • 製品開発
    • 合併と買収
    • コラボレーションとパートナーシップ
    • 合意
  • 市場参入戦略
  • COVID-19影響分析

第4章 生物学的データ可視化市場の分類：技術の推定・動向分析

  • 市場：テクニック変動分析、2021 &2030
  • 顕微鏡検査
  • 磁気共鳴画像
  • シーケンシング
  • X線結晶学
  • その他

第5章 生物学的データ可視化市場の分類：アプリケーションの推定・動向分析

  • 生体データ可視化市場：アプリケーションの変動分析、2021年と2030年
  • 細胞および生物のイメージング
  • 構造生物学と分子モデリング
  • ゲノム解析
  • アラインメント、系統発生、および進化
  • システム生物学

第6章 生物学的データ可視化市場の分類：プラットフォームの推定・動向分析

  • 生体データ可視化市場：プラットフォームの変動分析、2021 &2030
  • ウィンドウズ
  • マックOS
  • Linux
  • その他

第7章 生物学的データ可視化市場の分類：最終用途の推定・動向分析

  • 市場：最終用途の変動分析、2021年および2030年
  • 学術調査
  • 病院と診療所
  • 製薬およびバイオテクノロジー企業
  • その他

第8章 生物学的データ可視化市場の分類：技術、アプリケーション、プラットフォーム、最終用途別の地域推定・動向分析

  • 生体データ可視化市場：地域変動分析、2021年および2030年
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東およびアフリカ（MEA）
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第9章 競合情勢

  • 戦略的枠組み
  • 市場参加の分類
  • 主要な市場参入企業別最近の動向と影響分析
  • 公開会社
    • 著名な業界プレーヤーの普及と成長見通しのマッピング、2021年
  • 非公開会社
    • 主要新興企業一覧
  • 企業プロファイル
    • 3M
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Thermo Fisher Scientific, Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Tableau Software, LLC
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Agilent Technologies Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • QIAGEN
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • ZEISS International
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Oxford Instruments
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Olympus Corporation
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Clarivate
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • General Electric Company
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
図表

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Global Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 4 Global Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 5 Global Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 6 Global Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 7 Global Biological Data Visualization, by Region, 2018 - 2030 (USD Million)
  • TABLE 8 North America Biological Data Visualization, by Country, 2018 - 2030 (USD Million)
  • TABLE 9 North America Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 10 North America Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 11 North America Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 12 North America Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 13 U.S. Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 14 U.S. Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 15 U.S. Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 16 U.S. Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 17 Canada Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 18 Canada Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 19 Canada Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 20 Canada Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 21 Europe Biological Data Visualization, by Country, 2018 - 2030 (USD Million)
  • TABLE 22 Europe Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 23 Europe Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 24 Europe Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 25 Europe Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 26 Germany Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 27 Germany Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 28 Germany Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 29 Germany Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 30 U.K. Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 31 U.K. Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 32 U.K. Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 33 U.K. Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 34 France Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 35 France Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 36 France Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 37 France Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 38 Italy Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 39 Italy Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 40 Italy Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 41 Italy Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 42 Spain Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 43 Spain Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 44 Spain Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 45 Spain Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 46 Asia Pacific Biological Data Visualization, by Country, 2018 - 2030 (USD Million)
  • TABLE 47 Asia Pacific Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 48 Asia Pacific Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 49 Asia Pacific Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 50 Asia Pacific Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 51 China Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 52 China Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 53 China Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 54 China Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 55 Japan Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 56 Japan Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 57 Japan Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 58 Japan Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 59 India Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 60 India Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 61 India Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 62 India Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 63 South Korea Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 64 South Korea Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 65 South Korea Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 66 South Korea Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 67 Australia Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 68 Australia Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 69 Australia Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 70 Australia Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 71 Latin America Biological Data Visualization, by Country, 2018 - 2030 (USD Million)
  • TABLE 72 Latin America Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 73 Latin America Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 74 Latin America Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 75 Latin America Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 76 Brazil Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 77 Brazil Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 78 Brazil Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 79 Brazil Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 80 Mexico Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 81 Mexico Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 82 Mexico Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 83 Mexico Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 84 Argentina Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 85 Argentina Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 86 Argentina Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 87 Argentina Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 88 Middle East & Africa Biological Data Visualization, by Country, 2018 - 2030 (USD Million)
  • TABLE 89 Middle East & Africa Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 90 Middle East & Africa Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 91 Middle East & Africa Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 92 Middle East & Africa Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 93 South Africa Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 94 South Africa Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 95 South Africa Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 96 South Africa Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 97 Saudi Arabia Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 98 Saudi Arabia Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 99 Saudi Arabia Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 100 Saudi Arabia Biological Data Visualization, End-use, 2018 - 2030 (USD Million)
  • TABLE 101 UAE Biological Data Visualization, by Technique, 2018 - 2030 (USD Million)
  • TABLE 102 UAE Biological Data Visualization, by Application, 2018 - 2030 (USD Million)
  • TABLE 103 UAE Biological Data Visualization, by Platform, 2018 - 2030 (USD Million)
  • TABLE 104 UAE Biological Data Visualization, End-use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain-Based Sizing & Forecasting
  • FIG. 6 Market Formulation & Validation
  • FIG. 7 Biological Data Visualization, Market Segmentation
  • FIG. 8 Market Snapshot, 2021
  • FIG. 9 Market Trends & Outlook
  • FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • FIG. 14 Porter's Five Forces Analysis
  • FIG. 15 Market Penetration Vs Growth Prospect Mapping, 2021
  • FIG. 16 Global Biological Data Visualization: Technique Movement Analysis
  • FIG. 17 Global Biological Data Visualization, for Microscopy, 2018 - 2030 (USD Million)
  • FIG. 18 Global Biological Data Visualization, for MAGNETIC resonance imaging, 2018 - 2030 (USD Million)
  • FIG. 19 Global Biological Data Visualization, for Sequencing, 2018 - 2030 (USD Million)
  • FIG. 20 Global Biological Data Visualization, for X-ray Crystallography, 2018 - 2030 (USD Million)
  • FIG. 21 Global Biological Data Visualization, for Others, 2018 - 2030 (USD Million)
  • FIG. 22 Global Biological Data Visualization: Application Movement Analysis
  • FIG. 23 Global Biological Data Visualization, for Cell and Organism Imaging, 2018 - 2030 (USD Million)
  • FIG. 24 Global Biological Data Visualization, for Structural biology and Molecular Modeling, 2018 - 2030 (USD Million)
  • FIG. 25 Global Biological Data Visualization, for Genomic Analysis, 2018 - 2030 (USD Million)
  • FIG. 26 Global Biological Data Visualization, for Alignments, phylogeny, and Evolution, 2018 - 2030 (USD Million)
  • FIG. 27 Global Biological Data Visualization, for Systems Biology, 2018 - 2030 (USD Million)
  • FIG. 28 Global Biological Data Visualization: Platform Movement Analysis
  • FIG. 29 Global Biological Data Visualization, for Windows, 2018 - 2030 (USD Million)
  • FIG. 30 Global Biological Data Visualization, for Mac OS, 2018 - 2030 (USD Million)
  • FIG. 31 Global Biological Data Visualization, for Linux, 2018 - 2030 (USD Million)
  • FIG. 32 Global Biological Data Visualization, for Others, 2018 - 2030 (USD Million)
  • FIG. 33 Global Biological Data Visualization: End-Use Movement Analysis
  • FIG. 34 Global Biological Data Visualization, for Academic Institutes & Research Centers, 2018 - 2030 (USD Million)
  • FIG. 35 Global Biological Data Visualization, for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
  • FIG. 36 Global Biological Data Visualization, for Others, 2018 - 2030 (USD Million)
  • FIG. 37 Regional Marketplace: Key Takeaways
  • FIG. 38 Regional Outlook, 2021 & 2030
  • FIG. 39 Global Biological Data Visualization: Region Movement Analysis
  • FIG. 40 North America Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 41 U.S. Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 42 Canada Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 43 Europe Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 44 Germany Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 45 U.K. Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 46 France Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 47 Italy Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 48 Spain Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 49 Asia Pacific Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 50 Japan Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 51 China Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 52 India Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 53 Australia Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 54 South Korea Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 55 Latin America Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 56 Brazil Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 57 Mexico Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 58 Argentina Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 59 Middle East and Africa Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 60 South Africa Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 61 Saudi Arabia Biological Data Visualization, 2018 - 2030 (USD Million)
  • FIG. 62 UAE Biological Data Visualization, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68038-504-5

Biological Data Visualization Market Growth & Trends:

The global biological data visualization market size is expected to reach USD 1.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.0% from 2022 to 2030. The growing research in genomics and proteomics is one of the major market drivers. Major companies in the market are focusing on strategic initiatives such as new product launches, mergers and acquisitions, and technological collaborations, to increase their share in the biological data visualization market. For instance, in August 2021, DNAnexus, Inc. announced that the standards of the biomedical informatics platform outperformed the online security policy objectives outlined in the U.S. Government's recent executive order. This helped build confidence in the product among NGS end-users and assisted in managing large biomedical information with high security.

The life-science researchers and practitioners rely on visualization techniques for solving a wide range of challenges in understanding and interpreting biological information. Rapid advancements in raw computing power and graphics processing power make visualization of biological information easier on commodity desktop platforms. Besides, the increase in the adoption Of Next-Generation Sequencing (NGS) techniques and other biological data-acquisition approaches, which generate new types and sets of data, necessitates the demand for visualization tools among researchers and scientists.

For instance, Spain has become an attractive and competitive market for NGS data analysis. In September 2020, the Government of Spain allocated USD 29.5 million for precision and genomic medicine, and data science. This investment aims to enhance the capacity of the regional health system and use scientific knowledge as a tool to embrace economic competitiveness by contributing to innovation. The total funds allocated for 2 years (2020-22) is USD 89.33 million. The segment of investment includes genomic medicine, big data health, predictive medicine, advanced and personalized therapy, and precision medicine training.

The COVID-19 pandemic resulted in increased usage of sequencing information analysis platform plays a crucial role in the detection and tracing of the virus and support the growth of the biological data visualization market. Various sequencing surveillance platforms and solutions are being deployed for the effective diagnosis of infection. Furthermore, key stakeholders are undertaking various strategic initiatives, such as collaborations and licensing for collaborative efforts, to combat the disease. For instance, in February 2021, the Canadian government invested USD 53 million to implement a multilayered approach to the diagnosis of COVID-19. The Canadian government will utilize genome sequencing and analysis technologies to achieve desired outcomes.

Technological advancements in analytical and business intelligence solutions coupled with rapid growth in big data and the rise in the need for faster decision-making are a few other drivers boosting the demand for visualization tools in the bioinformatics field. The sheer amount of high-dimensional biological information needs machine learning and advanced data visualization approaches so that it can be easily understandable by human experts.

On the other hand, the biological data visualization market is fragmented in nature with a substantial number of companies ranging from large global players to small mid-sized local or regional players. Some of the public key vendors operating in the market include QIAGEN, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Becton-Dickinson and Company, and 3M.

Biological Data Visualization Market Report Highlights:

  • By technique, sequencing is estimated to have a major market share in 2021. The large amount of information generated through sequencing needs data management solutions and platforms, resulting in high demand for tools & algorithms for biological research.
  • By application, the genomic analysis segment is anticipated to have a significant share of the biological data visualization market in 2021. Certain factors such as increasing investment for the development of new platforms, a positive approach toward the adoption of analytical solutions, and technological innovations are leveraging new product launches in this application.
  • By platform, Mac OS is anticipated to be the fastest-growing segment in the biological data visualization market. Since the operating system has a user-friendly and simple design with better in-built security features for protecting information.
  • By end-user, the academic research segment is estimated to have a majority of the market share in 2021. This is attributed to the use of next-generation sequencing (NGS), and X-ray crystallography methods during their research to implement data visualization tools. Thus, an increase in the implementation of such techniques in these facilities drives the demand for visualization tools to precisely observe their research findings in biological research.
  • North America is considered to be a dominating regional market for biological data visualization in 2021 owing to the local presence of key players in the region and a significant number of research projects related to genomic analysis and systems biology.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Country Wise Market: Base Estimates
  • 1.2 Global Market: CAGR Calculation
  • 1.3 Region-Based Segment Share Calculation
  • 1.4 Research Scope & Assumptions
  • 1.5 List of Data Sources
    • 1.5.1 Data for primary interviews, by sources
    • 1.5.2 Data for primary interviews, by region

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Biological Data Visualization Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market driver analysis
      • 3.2.1.1 Rapid growth of biological data
      • 3.2.1.2 Incorporation of artificial intelligence in analysis of biological data
      • 3.2.1.3 Growing demand for faster decision making
    • 3.2.2 Market restraint analysis
      • 3.2.2.1 User- interface challenges pertaining to data visualization
      • 3.2.2.2 Lack of computational consistency for data management
  • 3.3 Penetration & Growth Prospect Mapping for Application, 2021
  • 3.4 Biological Data Visualization Market-SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Major Deals & Strategic Alliances Analysis
    • 3.6.1 Product developments
    • 3.6.2 Merger & acquisition
    • 3.6.3 Collaboration & partnership
    • 3.6.4 Agreement
  • 3.7 Market Entry Strategies
  • 3.8 COVID-19 Impact Analysis

Chapter 4 Biological Data Visualization Market Categorization: Technique Estimates & Trend Analysis

  • 4.1 Market: Technique Movement Analysis, 2021 & 2030
  • 4.2 Microscopy
    • 4.2.1 Microscopy Market, 2018 - 2030 (USD Million)
  • 4.3 Magnetic Resonance Imaging
    • 4.3.1 MRI Market, 2018 - 2030 (USD Million)
  • 4.4 Sequencing
    • 4.4.1 Sequencing Market, 2018 - 2030 (USD Million)
  • 4.5 X-ray Crystallography
    • 4.5.1 X-ray crystallography Market, 2018 - 2030 (USD Million)
  • 4.6 Others
    • 4.6.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Biological Data Visualization Market Categorization: Application Estimates & Trend Analysis

  • 5.1 Biological Data Visualization Market: Application Movement Analysis, 2021 & 2030
  • 5.2 Cell and Organism Imaging
    • 5.2.1 Cell and Organism Imaging Market, 2018 - 2030 (USD Million)
  • 5.3 Structural Biology and Molecular Modeling
    • 5.3.1 Structural Biology and Molecular Modeling Market, 2018 - 2030 (USD Million)
  • 5.4 Genomic Analysis
    • 5.4.1 Genomic Analysis Market, 2018 - 2030 (USD Million)
  • 5.5 Alignments, Phylogeny, and Evolution
    • 5.5.1 Alignments, Phylogeny, And Evolution Market, 2018 - 2030 (USD Million)
  • 5.6 Systems Biology
    • 5.6.1 Systems Biology Market, 2018 - 2030 (USD Million)

Chapter 6 Biological Data Visualization Market Categorization: Platform Estimates & Trend Analysis

  • 6.1 Biological Data Visualization Market: Platform Movement Analysis, 2021 & 2030
  • 6.2 Windows
    • 6.2.1 Windows Market, 2018 - 2030 (USD Million)
  • 6.3 MAC OS
    • 6.3.1 MAC OS Market, 2018 - 2030 (USD Million)
  • 6.4 Linux
    • 6.4.1 Linux Market, 2018 - 2030 (USD Million)
  • 6.5 Others
    • 6.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 Biological Data Visualization Market Categorization: End-use Estimates & Trend Analysis

  • 7.1 Market: End-use Movement Analysis, 2021 & 2030
  • 7.2 Academic Research
    • 7.2.1 Academic Research Market, 2018 - 2030 (USD Million)
  • 7.3 Hospitals & Clinics
    • 7.3.1 Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 7.4 Pharmaceutical & Biotechnology Companies
    • 7.4.1 Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 7.5 Others
    • 7.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 8 Biological Data Visualization Market Categorization: Regional Estimates & Trend Analysis, by Technique, Application, Platform, & End-use

  • 8.1 Biological Data Visualization Market: Regional Movement Analysis, 2021 & 2030
  • 8.2 North America
    • 8.2.1 North America biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.2.2 North America biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.2.3 North America biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.2.4 North America biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.2.5 U.S.
      • 8.2.5.1 U.S. biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.2.5.2 U.S. biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.2.5.3 U.S. biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.2.5.4 U.S. biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.2.6 Canada
      • 8.2.6.1 Canada biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.2.6.2 Canada biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.2.6.3 Canada biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.2.6.4 Canada biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.3.2 Europe biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.3.3 Europe biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.3.4 Europe biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.3.5 Germany
      • 8.3.5.1 Germany biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.3.5.2 Germany biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.3.5.3 Germany biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.3.5.4 Germany biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.3.6 U.K.
      • 8.3.6.1 U.K. biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.3.6.2 U.K. biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.3.6.3 U.K. biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.3.6.4 U.K. biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.3.7 France
      • 8.3.7.1 France biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.3.7.2 France biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.3.7.3 France biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.3.7.4 France biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.3.8 Italy
      • 8.3.8.1 Italy biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.3.8.2 Italy biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.3.8.3 Italy biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.3.8.4 Italy biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.3.9 Spain
      • 8.3.9.1 Spain biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.3.9.2 Spain biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.3.9.3 Spain biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.3.9.4 Spain biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific biological data visualization market, 2018 - 2030 (USD Million)
    • 8.4.2 Asia Pacific biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.4.3 Asia Pacific biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.4.4 Asia Pacific biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.4.5 Japan
      • 8.4.5.1 Japan biological data visualization market, 2018 - 2030 (USD Million)
      • 8.4.5.2 Japan biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.4.5.3 Japan biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.4.5.4 Japan biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.4.6 China
      • 8.4.6.1 China biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.4.6.2 China biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.4.6.3 China biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.4.6.4 China biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.4.7 India
      • 8.4.7.1 India biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.4.7.2 India biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.4.7.3 India biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.4.7.4 India biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.4.8 South Korea
      • 8.4.8.1 South Korea biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.4.8.2 South Korea biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.4.8.3 South Korea biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.4.8.4 South Korea biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.4.9 Australia
      • 8.4.9.1 Australia biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.4.9.2 Australia biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.4.9.3 Australia biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.4.9.4 Australia biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.5.2 Latin America biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.5.3 Latin America biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.5.4 Latin America biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.5.5 Brazil
      • 8.5.5.1 Brazil biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.5.5.2 Brazil biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.5.5.3 Brazil biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.5.5.4 Brazil biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.5.6 Mexico
      • 8.5.6.1 Mexico biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.5.6.2 Mexico biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.5.6.3 Mexico biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.5.6.4 Mexico biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.5.7 Argentina
      • 8.5.7.1 Argentina biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.5.7.2 Argentina biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.5.7.3 Argentina biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.5.7.4 Argentina biological data visualization market, by end-use, 2018 - 2030 (USD Million)
  • 8.6 Middle East and Africa (MEA)
    • 8.6.1 MEA biological data visualization market, by technique, 2018 - 2030 (USD Million)
    • 8.6.2 MEA biological data visualization market, by application, 2018 - 2030 (USD Million)
    • 8.6.3 MEA biological data visualization market, by platform, 2018 - 2030 (USD Million)
    • 8.6.4 MEA biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.6.5 South Africa
      • 8.6.5.1 South Africa biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.6.5.2 South Africa biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.6.5.3 South Africa biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.6.5.4 South Africa biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.6.6 Saudi Arabia
      • 8.6.6.1 Saudi Arabia biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.6.6.2 Saudi Arabia biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.6.6.3 Saudi Arabia biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.6.6.4 Saudi Arabia biological data visualization market, by end-use, 2018 - 2030 (USD Million)
    • 8.6.7 UAE
      • 8.6.7.1 UAE biological data visualization market, by technique, 2018 - 2030 (USD Million)
      • 8.6.7.2 UAE biological data visualization market, by application, 2018 - 2030 (USD Million)
      • 8.6.7.3 UAE biological data visualization market, by platform, 2018 - 2030 (USD Million)
      • 8.6.7.4 UAE biological data visualization market, by end-use, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Strategy Framework
  • 9.2 Market Participation Categorization
  • 9.3 Recent Developments & Impact Analysis, by Key Market Participants
  • 9.4 Public Companies
    • 9.4.1 Penetration & growth prospect mapping for prominent industry players, 2021
  • 9.5 Private Companies
    • 9.5.1 List of key emerging companies
  • 9.6 Company Profiles
    • 9.6.1 3M
      • 9.6.1.1 Company overview
      • 9.6.1.2 Financial performance
      • 9.6.1.3 Product benchmarking
      • 9.6.1.4 Strategic initiatives
    • 9.6.2 Thermo Fisher Scientific, Inc.
      • 9.6.2.1 Company overview
      • 9.6.2.2 Financial performance
      • 9.6.2.3 Product benchmarking
      • 9.6.2.4 Strategic initiatives
    • 9.6.3 Tableau Software, LLC
      • 9.6.3.1 Company overview
      • 9.6.3.2 Financial performance
      • 9.6.3.3 Product benchmarking
      • 9.6.3.4 Strategic initiatives
    • 9.6.4 Agilent Technologies Inc.
      • 9.6.4.1 Company overview
      • 9.6.4.2 Financial performance
      • 9.6.4.3 Product benchmarking
      • 9.6.4.4 Strategic initiatives
    • 9.6.5 QIAGEN
      • 9.6.5.1 Company overview
      • 9.6.5.2 Financial performance
      • 9.6.5.3 Product benchmarking
      • 9.6.5.4 Strategic initiatives
    • 9.6.6 ZEISS International
      • 9.6.6.1 Company overview
      • 9.6.6.2 Financial performance
      • 9.6.6.3 Product benchmarking
      • 9.6.6.4 Strategic initiatives
    • 9.6.7 Oxford Instruments
      • 9.6.7.1 Company overview
      • 9.6.7.2 Financial performance
      • 9.6.7.3 Product benchmarking
      • 9.6.7.4 Strategic initiatives
    • 9.6.8 Olympus Corporation
      • 9.6.8.1 Company overview
      • 9.6.8.2 Financial performance
      • 9.6.8.3 Product benchmarking
      • 9.6.8.4 Strategic initiatives
    • 9.6.9 Clarivate
      • 9.6.9.1 Company overview
      • 9.6.9.2 Financial performance
      • 9.6.9.3 Product benchmarking
      • 9.6.9.4 Strategic initiatives
    • 9.6.10 General Electric Company
      • 9.6.10.1 Company overview
      • 9.6.10.2 Financial performance
      • 9.6.10.3 Product benchmarking
      • 9.6.10.4 Strategic initiatives